Methods for estimating serological correlates of protectionSIBER, G. R.Developments in biological standardization. 1997, Num 89, pp 283-296, issn 0301-5149Conference Paper

Preparation and composition of acellular pertussis vaccines. Consideration of potential effects on vaccine efficacyHEWLETT, E. L.Developments in biological standardization. 1997, Num 89, pp 143-151, issn 0301-5149Conference Paper

Common side effects in the Italian and Stockholm I trialsTOZZI, A. E; OLIN, P.Developments in biological standardization. 1997, Num 89, pp 105-108, issn 0301-5149Conference Paper

Comparison of serological results in the NIAID multicenter acellular pertussis trial with recent efficacy trialsEDWARDS, K. M; DECKER, M. D.Developments in biological standardization. 1997, Num 89, pp 265-273, issn 0301-5149Conference Paper

European union research strategies on vaccinesHANSEN, B.Developments in biological standardization. 1997, Num 89, pp 29-36, issn 0301-5149Conference Paper

Implications of different study designs for the evaluation of acellular pertussis vaccinesFINE, P. E. M.Developments in biological standardization. 1997, Num 89, pp 123-133, issn 0301-5149Conference Paper

Issues regarding future research on pertussis vaccinesBURNS, D.Developments in biological standardization. 1997, Num 89, issn 0301-5149, p.377Conference Paper

Regulatory issues concerning pertussis vaccinesTIRU, M.Developments in biological standardization. 1997, Num 89, issn 0301-5149, p.341Conference Paper

Some thoughts for future pertussis research in EuropePLETSCHETTE, M.Developments in biological standardization. 1997, Num 89, issn 0301-5149, p.391Conference Paper

Acellular pertussis vaccines : The next stepHALPERIN, S. A.Developments in biological standardization. 1997, Num 89, pp 363-365, issn 0301-5149Conference Paper

Diagnostic polymerase chain reactionREIZENSTEIN, E.Developments in biological standardization. 1997, Num 89, pp 247-254, issn 0301-5149Conference Paper

Isolation, identification and characterization of Bordetella pertussisGUISO, N.Developments in biological standardization. 1997, Num 89, pp 233-238, issn 0301-5149Conference Paper

Pertussis : A worldwide problemIVANOFF, B; ROBERTSON, S. E.Developments in biological standardization. 1997, Num 89, pp 3-13, issn 0301-5149Conference Paper

Public health implications : United KingdomMILLER, E.Developments in biological standardization. 1997, Num 89, pp 367-368, issn 0301-5149Conference Paper

The role of Bordetella pertussis infections in adults in the epidemiology of pertussisCHERRY, J. D.Developments in biological standardization. 1997, Num 89, pp 181-186, issn 0301-5149Conference Paper

International Symposium on Pertussis Vaccine TrialsBROWN, Fred; GRECO, Donato; MASTRANTONIO, Paola et al.Developments in biological standardization. 1997, Num 89, issn 0301-5149, 423 p.Conference Proceedings

Absolute and relative efficacy of whole-cell vaccinesJAFARI, H. S.Developments in biological standardization. 1997, Num 89, pp 167-170, issn 0301-5149Conference Paper

Factors influencing antibody responses to acellular pertussis vaccinesTROLLFORS, B.Developments in biological standardization. 1997, Num 89, pp 279-282, issn 0301-5149Conference Paper

Japanese experience with 60 million doses of acellular pertussis vaccinesSATO, H.Developments in biological standardization. 1997, Num 89, pp 327-329, issn 0301-5149Conference Paper

Public health application of acellular pertussis vaccinesHADLER, S. C; ORENSTEIN, W. A.Developments in biological standardization. 1997, Num 89, pp 355-361, issn 0301-5149Conference Paper

Regulatory and standardization issuesWINSNES, R.Developments in biological standardization. 1997, Num 89, pp 349-350, issn 0301-5149Conference Paper

Diagnostic pertussis serology in the recent clinical efficacy studies of acellular vaccinesHALLANDER, H. O.Developments in biological standardization. 1997, Num 89, pp 205-212, issn 0301-5149Conference Paper

Epidemiological determinants of pertussisMILLER, E; GAY, N. J.Developments in biological standardization. 1997, Num 89, pp 15-23, issn 0301-5149Conference Paper

Epidemiology of pertussis and use of acellular pertussis vaccines in JapanKUNO-SAKAI, H; KIMURA, M.Developments in biological standardization. 1997, Num 89, pp 331-332, issn 0301-5149Conference Paper

Safety of acellular pertussis vaccine : Follow-up studiesCHEN, R. T.Developments in biological standardization. 1997, Num 89, pp 373-375, issn 0301-5149Conference Paper